Robert M. Califf, MD, was sworn in as the new commissioner of the U.S. Food and Drug Administration (FDA) on February 17, 2022.
Previously, Dr. Califf served as FDA commissioner from February 2016–February 2017. Prior to rejoining the FDA, Dr. Califf was head of medical strategy and senior advisor at Alphabet Inc., contributing to strategy and policy for its health subsidiaries, Verily Life Sciences and Google Health. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute.
A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health-care quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,300 publications in the peer-reviewed literature.
Dr. Califf will now oversee the federal agency tasked with finalizing and implementing over-the-counter hearing aid regulations.
Recent Posts
Appropriations Update
As Congress returns from the August recess, its primary goal is to pass the appropriations bills that fund the federal government by September 30, 2025….
Clinical Decision Support for Vestibular Diagnosis: Large-Scale Machine Learning with Lived Experience Coaching
Pastor et al. (2025) developed a machine learning system (MLS) to help make a vestibular diagnosis based on patient symptoms. They utilized diagnostic data from…
Academy Submits Comments on Proposed Revisions to MPFS CY 2026
In response to the Centers for Medicare and Medicaid Services (CMS) Notice of Proposed Rulemaking (NPRM) regarding revisions to Medicare payment policies under the Medicare…